UPC
Universe Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$4.86
+2.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.44x
- Price / sales
- 1.38x
- Price / cash flow
- -2.05x
Enterprise value
- Enterprise value
- $4.9M
- EV / sales
- 0.28x
- EV / EBITDA
- -3.77x
- EV / EBIT
- -2.36x
- Market cap
- $24.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026